Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235755
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2005-10-06
Brief Title:
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline